EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Comparisons

Should the clinic use one pharmacy, two pharmacies, or a routing platform?

Dose Diligence research deskSection 03 · Page 9 of 12Last updated 17 Nov 2026

Our preferred starting design is a primary route plus a validated fallback—not automatic equal splitting and not untested exclusivity. Choose the structure according to the interruption you are trying to withstand.

Operating approachRecommended fitMain trade-off to testRequired proof before launch
Single primary partnerA bounded cohort with a stable workflow and a credible external contingencySimpler operating model versus concentrated exposureExit data, escalation ownership and demonstrated recovery process
Primary partner plus tested fallbackMulti-state providers for whom interruptions would affect many patientsAdditional diligence and readiness costState/product eligibility, real acceptance testing and documented spare capacity
Active multi-pharmacy routingOrganisations with sufficient operations and engineering capabilityRouting flexibility versus more complex reconciliation and exception handlingPharmacy-specific event coverage, cancellation controls and patient-choice workflow
Manufacturer access alongside an appointed partnerCohorts with different payment or product needsMore access pathways versus fragmented communicationsClear routing rules, affordability checks and duplicate-order prevention

These are design judgements, not measured category failure rates.

Do not mistake a software status for a completed fill. Photon's documentation distinguishes statuses such as sent, received and ready, and explains that available states differ by pharmacy integration. A received prescription is not proof of delivery. (docs.photon.health)

Which metrics should an SLA use?

Request definitions before negotiating targets:

MetricRecommended definition or breakdown
Prescription acceptanceAccepted valid prescriptions divided by submitted valid prescriptions; report rejection reasons
Time to patient contactReceipt to first successful contact, not merely an attempted message
Time to dispenseReport from receipt and separately from completion of payment, authorisation and clarification
On-time fulfilmentSupply received or collected by the agreed deadline divided by supply expected
Exception burdenExceptions and staff minutes per 100 expected fills
Integrity failuresDamaged, incorrect or temperature-questioned deliveries, with investigation and disposition
Replacement resolutionTime to a clinically and operationally appropriate resolution, not simply a ticket acknowledgement
Coverage accuracyOrders rejected despite the supplier having represented that the state/product combination was supported

Report medians and tail performance, such as the 90th percentile, rather than averages alone. Exclude a case from an SLA only under a documented rule; retain excluded cases in the patient-access dashboard.

What should a transition test cover?

Before moving the whole network, test representative state, product, payment and presentation combinations. Include incomplete prescriptions, unreachable patients, failed payments, stockouts, address changes and cancelled orders.

Assign owners for:

  • Outstanding paid and unpaid orders.
  • Prescription transfers or replacement prescriptions where appropriate.
  • Patient communications and support.
  • Duplicate prevention and cancellation confirmation.
  • Financial reconciliation and refunds.
  • Data export and historical reporting.
  • Clinical review when the interruption could affect treatment.

Do not make automated therapeutic substitutions or dose conversions part of a procurement fallback. Escalate those decisions to the treating clinician.

Explore the table row by row

A working view of the research

Single primary partner

Recommended fit
A bounded cohort with a stable workflow and a credible external contingency
Main trade-off to test
Simpler operating model versus concentrated exposure
Required proof before launch
Exit data, escalation ownership and demonstrated recovery process

Sources cited on this page

  1. docs.photon.health · Source 1 ↗https://docs.photon.health/docs/order-rx-status-retail-pharmacycourier-delivery
Section sources →